As of February 2026 MyoKardia has a market cap of A$16.88 Billion. This makes MyoKardia the world's 1800th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.